SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-20-017022
Filing Date
2020-08-31
Accepted
2020-08-31 17:31:37
Documents
68
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 856538
2 ex1-2.htm EX-1.2 269602
3 ex5-1.htm EX-5.1 12815
4 ex31-1.htm EX-31.1 22448
5 ex31-2.htm EX-31.2 20193
6 ex32-1.htm EX-32.1 6596
7 ex32-2.htm EX-32.2 6652
  Complete submission text file 0001493152-20-017022.txt   5132891

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE crbp-20200630.xsd EX-101.SCH 41550
9 XBRL CALCULATION FILE crbp-20200630_cal.xml EX-101.CAL 48301
10 XBRL DEFINITION FILE crbp-20200630_def.xml EX-101.DEF 193527
11 XBRL LABEL FILE crbp-20200630_lab.xml EX-101.LAB 352563
12 XBRL PRESENTATION FILE crbp-20200630_pre.xml EX-101.PRE 296323
13 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 605084
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37348 | Film No.: 201152688
SIC: 2834 Pharmaceutical Preparations